Sixty-three percent of patients using GLP-1 medications are new to aesthetics. Significant weight loss changed their face in ways they didn’t anticipate — volume loss, skin laxity, deepened folds — and they’re showing up in practices for the first time.
For providers, this patient represents both a clinical challenge and a revenue opportunity. Serving them well requires more than strong injection technique. It requires a practice model built for someone managing two significant healthcare costs at once: a conversation, treatment plan, and payment structure calibrated to where they actually are.
What you will learn in this article:
Before the clinical picture, look at the financial one — because it shapes everything else. McKinsey’s 2025 survey of 174 aesthetics providers found that 60% of GLP-1 patients have reduced their overall cosmetic spending — significant monthly drug costs are competing directly with aesthetics budgets. Only 40% are spending more on aesthetic treatments. That data shapes the practice model: payment plans, phased protocols, and high-impact conservative first treatments rather than a full menu on visit one.
The 40% spending more on aesthetics skew heavily toward patients already enrolled in a weight management program. GLP-1 weight management and aesthetics work as a natural practice pairing — and providers offering both have a structural advantage in capturing and retaining this patient that single-service practices don’t. IAPAM’s Aesthetic Medicine Symposium includes weight management training for providers who want to add that capability alongside their aesthetic skills.
Allergan Aesthetics data puts numbers to what providers are seeing in the treatment room. Facial volume loss affects 61% of GLP-1 patients. Skin laxity affects 50%. Wrinkles and deepened folds affect 35%.
The mechanism is straightforward: rapid fat loss deflates facial scaffolding faster than skin can adapt. The result looks different from normal aging — volume loss that’s often more diffuse, laxity that arrived quickly rather than gradually, and a neck that’s frequently affected alongside the face.
Patients are often caught off guard. They lost the weight they were working toward and then faced an aesthetic outcome they didn’t expect. That’s the conversation they’re bringing to your practice.
A peer-reviewed study providing experience-based clinical guidance for nonsurgical aesthetic treatment of the face and neck in GLP-1 weight loss patients gives providers a current framework to work from. Key points: HA fillers are the primary treatment tool, cited by 81% of providers in the Allergan data.
Multiple-visit planning is standard — this isn’t a one-session correction. And timing matters significantly: avoid over-treating during active weight loss. A patient still losing weight presents differently than one who has been stable for several months. Treating aggressively too early means repeated sessions as the face continues to change.
Conservative, staged treatment during the active loss phase is both clinically sound and better for the patient relationship long-term. Also see IAPAM’s April 2026 GLP-1 Practice Updates for the latest on how this guidance is evolving.
A few intake adjustments make a significant difference with this patient type:
Patients respond well to a clear roadmap. It frames the relationship as collaborative rather than reactive, and it naturally sets up the multi-visit model.
The 63% of GLP-1 patients new to aesthetics represent a genuine patient acquisition opportunity — but not through the conventional first-visit conversion model. Most need multiple sessions over time, are budget-constrained by drug costs, and will respond better to a provider who treats them as a long-term partner than one who leads with a full treatment menu.
Flexible payment options, staged plans, and positioning the practice around the whole patient journey — weight loss and aesthetic recovery together — is what converts a first-time visitor into a multi-year client.
The provider who tries to close a large package on the first visit will lose most of them. The one who maps out a reasonable 12–18 month journey alongside their weight management keeps them.
For a broader picture of where GLP-1s are reshaping practice economics, the IAPAM Medical Weight Management Library and WHO guidance on GLP-1s in medical weight management are worth reviewing.
Serving GLP-1 aesthetic patients well means being competent on both sides of their care. For providers not yet offering weight management: the Certified Medical Weight Management Provider Program covers the clinical and business infrastructure to add GLP-1 services to an existing practice. For providers who want to deepen their aesthetic skills to address the facial changes this patient presents with: the Certified Aesthetic Provider Program covers the clinical depth needed. The practices winning with this patient type are the ones prepared on both fronts.
What is “GLP-1 face”?
“GLP-1 face” is an informal term for the facial changes that occur with significant GLP-1-driven weight loss — primarily volume loss, skin laxity, and deepened folds. The underlying mechanism is the same as weight-loss-related facial aging in general: rapid fat loss deflates the scaffolding of the face faster than the skin can adapt. What makes GLP-1 patients a distinct clinical group is the pace of the change and the fact that many are new to aesthetic medicine and weren’t anticipating this outcome.
When is the right time to treat a GLP-1 patient aesthetically?
Timing depends on where the patient is in their weight loss journey. During active weight loss, conservative treatment focused on skin quality and laxity is appropriate — avoid significant volume restoration while the face is still changing. Once weight has stabilized for several months, more definitive volume work makes sense. Setting this expectation clearly at the first consultation prevents both clinical complications and patient disappointment.
Can GLP-1 patients get dermal fillers?
Yes, with appropriate timing and clinical judgment. HA fillers are the most commonly used tool for GLP-1-related facial volume loss, cited by 81% of providers in Allergan Aesthetics data. The key consideration is treatment timing — conservative use during active weight loss, with more comprehensive volume restoration after the patient has stabilized. Multiple sessions over time typically produce better outcomes than a single large treatment.
Why are some GLP-1 patients spending less on aesthetic treatments?
Monthly GLP-1 medication costs are significant, and for many patients they compete directly with aesthetics budgets. McKinsey’s 2025 survey found that 60% of GLP-1 patients have reduced their overall cosmetic spending for exactly this reason. Providers who understand this dynamic — and offer payment plans, phased treatment options, and a long-term relationship model — are better positioned to retain these patients than those expecting a conventional high-spend first visit.
What aesthetic treatments work best for GLP-1-related skin laxity?
Current peer-reviewed guidance points to a staged approach: address skin quality and laxity early in the treatment journey, then move to volume restoration once weight is stable. HA fillers are the primary volume tool. Energy-based devices for skin tightening may play a role as part of a longer treatment plan. The specific protocol depends on the individual patient’s rate of weight loss, areas of concern, and point of stability — which is why the intake framework and re-evaluation checkpoints matter as much as the treatment choice itself.
Should I offer weight management and aesthetics together in my practice?
From a revenue standpoint, yes — the data supports it. The 40% of GLP-1 patients spending more on aesthetics are disproportionately patients already enrolled in weight management programs. A practice that serves both needs is positioned for a longer, higher-value patient relationship than one that handles only one side. The Certified Medical Weight Management Provider Program is the structured path to adding that capability if it’s not already in place.
Get Your Free GLP-1 Quick Start Action Plan
Request your Quick Start Checklist for Starting or Integrating a New GLP-1 for Weight Loss Guide.
